Invention Grant
- Patent Title: Method for treating autoimmune disease using CD4 T-cells with engineered stabilization of expression of endogenous FOXP3 gene
-
Application No.: US16345622Application Date: 2016-10-31
-
Publication No.: US11712454B2Publication Date: 2023-08-01
- Inventor: Andrew M. Scharenberg , David J. Rawlings , Troy Torgerson
- Applicant: Seattle Children's Hospital
- Applicant Address: US WA Seattle
- Assignee: SEATTLE CHILDREN'S HOSPITAL
- Current Assignee: SEATTLE CHILDREN'S HOSPITAL
- Current Assignee Address: US WA Seattle
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2016/059729 2016.10.31
- International Announcement: WO2018/080541A 2018.05.03
- Date entered country: 2019-04-26
- Main IPC: A61K35/545
- IPC: A61K35/545 ; C12N15/85 ; C12N15/10 ; C12N15/66 ; A61K48/00 ; A61P37/06 ; A61K38/20 ; C12N5/0789 ; C12N15/52

Abstract:
Disclosed are methods of making a genetically cell that expressed FOXP3 and methods of treatment. In some embodiments, the method can providing a first nucleotide sequence, wherein the first nucleotide sequence comprises a coding strand, the coding strand comprising one or more regulatory elements and a FOXP3 gene or portion thereof providing a nuclease and performing a gene editing process on the first nucleotide sequence, which edits said one or more regulatory elements, and optionally edits the FOXP3 gene or portion thereof. Methods of treating a subject suffering from an autoimmune disease and subjects suffering the effects of organ transplantation are also provided.
Public/Granted literature
Information query
IPC分类: